These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10426866)

  • 21. Modulation of the myocardial response to ischemia.
    Buja LM
    Lab Invest; 1998 Nov; 78(11):1345-73. PubMed ID: 9840611
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of early necrosis in a canine model of low flow myocardial ischemia using 125I-antimyosin (Fab')2.
    Timmis AD; Lopez JA; Fallon JT; Khaw BA; Haber E; Powell WJ
    J Appl Cardiol; 1987; 2(3):185-211. PubMed ID: 11540157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.
    Kloner RA; Jennings RB
    Circulation; 2001 Dec; 104(24):2981-9. PubMed ID: 11739316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Postischemic changes in the permeability of coronary microcirculation and ventricular remodeling].
    Barsotti A; Di Napoli P; Soccio M; Di Muzio M; Spoletini L; Dini FL; Gallina S; D'Annunzio E; Modesti A
    Cardiologia; 1995 Dec; 40(12 Suppl 1):57-65. PubMed ID: 8998776
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathophysiology of acute myocardial infarction.
    Burke AP; Virmani R
    Med Clin North Am; 2007 Jul; 91(4):553-72; ix. PubMed ID: 17640536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary microcirculation changes during myocardial stunning in dogs.
    Luo Y; Cha DG; Liu YL; Zhou SF
    Cardiology; 2010; 117(1):68-74. PubMed ID: 20924181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
    Jaffe R; Dick A; Strauss BH
    JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA).
    Zhao L; Kirsch CC; Hagen SR; Elliott GT
    J Mol Cell Cardiol; 1996 Jan; 28(1):197-208. PubMed ID: 8745227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myocardial retroperfusion: the idea, the experimentation, the clinical perspectives].
    Volpini M; Oh BH
    Cardiologia; 1990 Nov; 35(11):883-92. PubMed ID: 2099242
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
    Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial ischemia: lack of coronary blood flow, myocardial oxygen supply-demand imbalance, or what?
    Heusch G
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1439-H1446. PubMed ID: 31002282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion.
    Lefer DJ; Flynn DM; Phillips ML; Ratcliffe M; Buda AJ
    Circulation; 1994 Nov; 90(5):2390-401. PubMed ID: 7525107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparity in coronary perfusion and regional wall motion: effect on clinical assessment of viability.
    Hendel RC; Bonow RO
    Coron Artery Dis; 1993 Jun; 4(6):512-20. PubMed ID: 8261229
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction between coronary artery stenosis and coronary microcirculation in ischemic heart disease.
    Sambuceti G; Marzilli M; Marini C; L'Abbate A
    Z Kardiol; 2000; 89 Suppl 9():IX/126-31. PubMed ID: 11151782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation of myocardial microcirculation during mechanical reperfusion for myocardial ischemia with either abciximab or eptifibatide.
    Stoupakis G; Orlando J; Kalia H; Skurnick J; Saric M; Arora R
    J Invasive Cardiol; 2003 Sep; 15(9):476-80. PubMed ID: 12947204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of brief ischemia and reperfusion on the myocardium and the role of nitric oxide.
    Baker CS; Kumar S; Rimoldi OE
    Heart Fail Rev; 2003 Apr; 8(2):127-41. PubMed ID: 12766492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction?
    Heper G; Korkmaz ME; Kilic A
    Angiology; 2007 Dec-2008 Jan; 58(6):663-70. PubMed ID: 17989422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible myocardial dysfunction in sepsis and ischemia.
    Kan H; Failinger CF; Fang Q; Finkel MS
    Crit Care Med; 2005 Dec; 33(12):2845-7. PubMed ID: 16352971
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications.
    Li J; Zhang H; Zhang C
    J Mol Cell Cardiol; 2012 Apr; 52(4):865-72. PubMed ID: 21924274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.